These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 320014)

  • 1. Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.
    Vanderheeren FA; Muusze RG
    Eur J Clin Pharmacol; 1977 Jan; 11(2):135-40. PubMed ID: 320014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients.
    Muusze RG; Vanderheeren FA
    Eur J Clin Pharmacol; 1977 Jan; 11(2):141-7. PubMed ID: 837967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
    Shvartsburd A; Nwokeafor V; Smith RC
    Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
    Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
    Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioreceptor assay and high-performance liquid chromatography yield similar results for serum thioridazine and its major metabolites.
    Rao ML; Brown WA; Wagner R
    Ther Drug Monit; 1988; 10(2):184-7. PubMed ID: 3381236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioridazine plasma levels and clinical response.
    Gottschalk LA; Biener R; Noble EP; Birch H; Wilbert DE; Heiser JF
    Compr Psychiatry; 1975; 16(4):323-37. PubMed ID: 1098848
    [No Abstract]   [Full Text] [Related]  

  • 8. A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.
    Cohen BM; Lipinski JF; Waternaux C
    Psychopharmacology (Berl); 1989; 97(4):481-8. PubMed ID: 2498945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels and clinical effects of thioridazine and thiothixene.
    Bergling R; Mjorndal T; Oreland L; Rapp W; Wold S
    J Clin Pharmacol; 1975; 15(2-3):178-86. PubMed ID: 1091665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effect and plasma level of thioridazine in schizophrenic patients (author's transl)].
    Klein HE; Chandra O; Matussek N
    Pharmakopsychiatr Neuropsychopharmakol; 1975 May; 8(3):122-31. PubMed ID: 1233515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot of plasma thioridazine and metabolites in chronically treated patients.
    Papadopoulos AS; Chand TG; Crammer JL; Lader S
    Br J Psychiatry; 1980 Jun; 136():591-6. PubMed ID: 7388266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of thioridazine metabolites and ECG abnormalities.
    Gottschalk LA; Dinovo E; Biener R; Nandi BR
    J Pharm Sci; 1978 Feb; 67(2):155-7. PubMed ID: 621628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a possible new metabolite of thioridazine and mesoridazine from human plasma.
    Dinovo EC; Gottschalk LA; Noble EP; Biener R
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):489-96. PubMed ID: 4824823
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of thioridazine on prolactin levels in acutely schizophrenic patients: challenge-dose and steady-state levels.
    Johnson GF; Hunt GE
    Aust N Z J Psychiatry; 1980 Jun; 14(2):127-31. PubMed ID: 6932868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics.
    Carlsson A; Roos BE; Wålinder J; Skott A
    J Neural Transm; 1973; 34(2):125-32. PubMed ID: 4146641
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum concentrations of thioridazine, its major metabolites and serum neuroleptic-like activities in schizophrenics with and without tardive dyskinesia.
    Widerlöv E; Häggström JE; Kilts CD; Andersson U; Breese GR; Mailman RB
    Acta Psychiatr Scand; 1982 Oct; 66(4):294-305. PubMed ID: 7148482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous assay of thioridazine and its major metabolites in plasma at single dosage levels with a novel report of two ring sulfoxides of thioridazine.
    Wells CE; Juenge EC; Furman WB
    J Pharm Sci; 1983 Jun; 72(6):622-5. PubMed ID: 6875822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with mesoridazine and thioridazine in chronic schizophrenia: I. Assessment of clinical and electrophysiologic responses in refractory hallucinating schizophrenics.
    Gardos G; Tecce JJ; Hartmann E; Bowers P; Cole JO
    Compr Psychiatry; 1978; 19(6):517-25. PubMed ID: 720036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.